$12.10
0.292.46%
At Close: -
$12.10
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Third Harmonic Bio
THRDNASDAQ
Third Harmonic Bio (NASDAQ:THRD) Stock, Analyst Ratings, Price Targets, Forecasts
Third Harmonic Bio Inc has a consensus price target of $12.9 based on the ratings of 5 analysts. The high is $23 issued by Stifel on June 18, 2024. The low is $3.6 issued by Jefferies on December 16, 2022. The 3 most-recent analyst ratings were released by Stifel, Raymond James, and Morgan Stanley on June 18, 2024, June 7, 2024, and August 11, 2023, respectively. With an average price target of $16 between Stifel, Raymond James, and Morgan Stanley, there's an implied 32.23% upside for Third Harmonic Bio Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Stifel
Raymond James
Morgan Stanley
Jefferies
1calculated from analyst ratings
Analyst Ratings for Third Harmonic Bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/18/2024 | Buy Now | 90.08% | Stifel | Alex Thompson | → $23 | Initiates | → Buy | Get Alert |
| 06/07/2024 | Buy Now | 48.76% | Raymond James | Laura Prendergast | → $18 | Initiates | → Outperform | Get Alert |
| 08/11/2023 | Buy Now | -42.15% | Morgan Stanley | Michael Ulz | $5 → $7 | Maintains | Equal-Weight | Get Alert |
| 12/16/2022 | Buy Now | -58.68% | Morgan Stanley | Michael Ulz | $34 → $5 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/16/2022 | Buy Now | -70.25% | Jefferies | Akash Tewari | $30 → $3.6 | Downgrade | Buy → Hold | Get Alert |
| 10/10/2022 | Buy Now | 147.93% | Jefferies | Akash Tewari | → $30 | Initiates | → Buy | Get Alert |
| 10/10/2022 | Buy Now | 180.99% | Morgan Stanley | Michael Ulz | → $34 | Initiates | → Overweight | Get Alert |
| 10/10/2022 | Buy Now | — | Cowen & Co. | Joseph Thome | — | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for Third Harmonic Bio (THRD) stock?
The latest price target for Third Harmonic Bio (NASDAQ:THRD) was reported by Stifel on June 18, 2024. The analyst firm set a price target for $23.00 expecting THRD to rise to within 12 months (a possible 90.08% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Third Harmonic Bio (THRD)?
The latest analyst rating for Third Harmonic Bio (NASDAQ:THRD) was provided by Stifel, and Third Harmonic Bio initiated their buy rating.
When was the last upgrade for Third Harmonic Bio (THRD)?
There is no last upgrade for Third Harmonic Bio
When was the last downgrade for Third Harmonic Bio (THRD)?
The last downgrade for Third Harmonic Bio Inc happened on December 16, 2022 when Morgan Stanley changed their price target from $34 to $5 for Third Harmonic Bio Inc.
When is the next analyst rating going to be posted or updated for Third Harmonic Bio (THRD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Third Harmonic Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Third Harmonic Bio was filed on June 18, 2024 so you should expect the next rating to be made available sometime around June 18, 2025.
Is the Analyst Rating Third Harmonic Bio (THRD) correct?
While ratings are subjective and will change, the latest Third Harmonic Bio (THRD) rating was a initiated with a price target of $0.00 to $23.00. The current price Third Harmonic Bio (THRD) is trading at is $12.10, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.